JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263242

Human KLHDC3 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

KLHDC3 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

View Alternative Names

KLDC3_HUMAN, Kelch domain-containing protein 3, PEAS, Protein Peas, RP1-20C7.3, Testis intracellular mediator protein, dJ20C7.3, hPEAS, kelch domain containing 3

1 Images
Sanger Sequencing - Human KLHDC3 knockout HEK-293T cell lysate (AB263242)
  • Sanger seq

Unknown

Sanger Sequencing - Human KLHDC3 knockout HEK-293T cell lysate (AB263242)

Homozygous : 1 bp insertion in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263242-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human KLHDC3 knockout HEK293T cell lysate", "number":"AB263242-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263242-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
KLHDC3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

KLHDC3 also known as Kelch Domain Containing 3 is a protein with a mass of approximately 30 kDa. It is characterized by the presence of a Kelch domain which enables protein-protein interactions. It is expressed in various tissues with notable presence in the brain and testes. This protein is part of the Kelch domain-containing family which often plays roles in scaffolding and organizing protein complexes within cells.
Biological function summary

KLHDC3 participates in cellular processes such as transcriptional regulation and cell cycle control. It is involved in forming protein complexes that modify transcriptional responses. These complexes interact with a variety of transcription factors impacting gene expression. KLHDC3 also regulates the stability and degradation of certain proteins by acting as an adapter for ubiquitination processes.

Pathways

KLHDC3 plays a role in critical pathways like the ubiquitin-proteasome system and the Wnt signaling pathway. It interacts with proteins involved in these pathways such as Beta-catenin influencing cellular growth and development. The ubiquitin-proteasome system is essential for protein turnover while Wnt signaling regulates gene transcription that affects embryogenesis and cell proliferation.

KLHDC3 has been linked to disorders like neurodegenerative diseases and certain cancers. Aberrant functioning of KLHDC3 or its related pathways can disrupt normal cellular processes leading to disease development. For example its interaction with Beta-catenin can influence pathways associated with tumor progression. Further research aims to understand how KLHDC3 modulations contribute to disease pathology and may guide therapeutic approaches.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com